Skip to content
- STIM: Revenue Growth and Positive Adjusted EBITDA Give the Rally Substance
- IMNN: ThermoDox Deal Gives a Written-Off Asset a New Path
- KTTA: Pasithea Approaches Its October 23 Cancer-Data Presentation
- SHFS: Nasdaq Gives Safe Harbor More Time as Shares Rebound
- NUAI: New Era’s AI Data-Center Plan Faces the Tenant Test
- PDSB: A New Board as PDS Biotech Prepares Its Next Cancer-Trial Push
- DFSC: From Army Demonstrations to Commercial Orders—DEFSEC’s Next Test
- XHLD: TEN Holdings Takes Its Digital-Experience Platform to Investors
- ESLA: Two Infusions, One Patient—and a Bigger Cancer-Therapy Question
- AMOD: Bitcoin Riches Meet the Per-Share Value Test
